Yüklüyor......
Gemfibrozil treatment: a comparison with clofibrate.
Gemfibrozil was found to be an effective hypotriglyceridaemic agent in types IV, IIb and V hyperlipoproteinaemia. When given at a dose level of 800 mg/day its activity was nearly of the same order of magnitude as 1.5 g/day of clofibrate.
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1976
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1864044/ https://ncbi.nlm.nih.gov/pubmed/190609 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|